Cann Group Ltd (ASX: CAN) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Cann Group Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $113.94 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 277.91 million
Earnings per share -0.109
Dividend per share N/A
Year To Date Return -30.51%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

CAN ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Cann Group Ltd

Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the company; the development and manufacture (via third party arrangements) of finished product formulations; and the pursuit and execution of various supply and offtake agreements with third parties.

CAN Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
11 Jun 2021 $0.41 $0.00 0.00% 425,988 $0.41 $0.42 $0.40
10 Jun 2021 $0.41 $-0.01 -2.41% 236,162 $0.41 $0.42 $0.41
09 Jun 2021 $0.42 $0.02 5.06% 663,595 $0.40 $0.42 $0.40
08 Jun 2021 $0.40 $-0.02 -4.82% 2,206,482 $0.42 $0.43 $0.40
07 Jun 2021 $0.42 $-0.01 -2.35% 686,930 $0.43 $0.43 $0.42
04 Jun 2021 $0.43 $0.00 0.00% 638,512 $0.43 $0.44 $0.43
03 Jun 2021 $0.43 $0.02 4.88% 1,439,417 $0.41 $0.44 $0.41
02 Jun 2021 $0.41 $-0.01 -2.41% 784,043 $0.42 $0.43 $0.41
01 Jun 2021 $0.42 $0.00 0.00% 291,071 $0.42 $0.43 $0.42
31 May 2021 $0.42 $-0.01 -2.38% 272,879 $0.42 $0.43 $0.42
28 May 2021 $0.42 $-0.02 -4.55% 1,615,997 $0.43 $0.44 $0.42
27 May 2021 $0.44 $0.00 0.00% 560,641 $0.45 $0.46 $0.44
26 May 2021 $0.44 $0.01 2.30% 217,411 $0.44 $0.45 $0.44
25 May 2021 $0.44 $-0.02 -4.44% 383,653 $0.45 $0.45 $0.43
24 May 2021 $0.45 $0.01 2.27% 373,066 $0.45 $0.45 $0.43
21 May 2021 $0.44 $0.01 2.33% 507,224 $0.43 $0.45 $0.42
20 May 2021 $0.43 $0.03 7.50% 720,473 $0.41 $0.44 $0.41
19 May 2021 $0.40 $0.00 0.00% 298,706 $0.41 $0.41 $0.40
18 May 2021 $0.40 $0.01 2.53% 347,669 $0.41 $0.41 $0.40
17 May 2021 $0.40 $-0.02 -4.88% 1,199,033 $0.41 $0.41 $0.39

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
09 Dec 2020 Douglas (Doug) Rathbone Transfer 90 $64,180
As advised by the company. Transfer of shares to Ann Rathbone from a
deceased estate through grant of probate.
13 Oct 2020 Philip Jacobsen Buy 100 $38,000
On-market trade.
12 Oct 2020 Philip Jacobsen Buy 43 $17,053
On-market trade.
15 Sep 2020 Philip Jacobsen Buy 1 $700,000
Placement.
15 Sep 2020 Geoffrey(Geoff) Pearce Buy 200 $80,000
Placement.
15 Sep 2020 Allan McCallum Buy 500 $200,000
Placement.
14 Sep 2020 Douglas (Doug) Rathbone Transfer 175 $73,500
As advised by the company. Transfer of shares to Ann Rathbone from a
deceased estate through grant of probate
03 Sep 2020 Philip Jacobsen Buy 56 $21,946
On-market trade.
01 Sep 2020 Philip Jacobsen Buy 200 $79,260
On-market trade.
20 Aug 2020 Philip Jacobsen Buy 75 $30,000
Participation in share purchase plan.
20 Aug 2020 Douglas (Doug) Rathbone Buy 225 $90,000
Participation in share purchase plan.
20 Aug 2020 Allan McCallum Buy 75 $30,000
Participation in share purchase plan.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Douglas (Doug) John Rathbone Non-Executive Director Mar 2015
Mr Rathbone is an experienced public company director and is a former Board member of the FERNZ Corporation and the CSIRO. He is Chairman of the Rathbone Wine Group and Chairman since 1 April 2018, Go Resources, Queenscliff Harbour Pty Ltd and AgBiTech. He is also a former member of the RABO Bank Advisory Board, an Honorary Life Governor of the Royal Children's Hospital and a former Director of the Burnett Centre for Medical Research. Doug brings to the Board experienced management and corporate governance skills together with a passion to grow the business having successfully transformed Nufarm to become one of the world's leading crop protection and seed companies with an global footprint. He is also member of Risk and Capital Committees.
Mr Allan D McCallum Non-Executive ChairmanNon-Executive Director Jan 2015
Mr McCallum has broad experience as a public company director in agribusiness and healthcare and have experience in strategy development and implementation and mergers and acquisitions. He is also member of Risk Committee and chairman of Capital Committees.
Mr John Stewart Sharman Non-Executive Director Apr 2021
Mr Sharman has an international business experience as a Managing Director, CEO, CFO and non-executive director with public and private companies, including several ASX listed entities. He has an understanding of the medical manufacturing industry as well as the pharmaceutical and nutraceutical sectors. He has led businesses with operations in Australia, the UK, Europe, Asia and the USA, building distribution, sales, marketing and manufacturing networks both locally and internationally. Mr Sharman is currently the CEO of Universal Biosensors Inc (ASX:UBI). Prior to that he served 10 years as CEO of Medical Developments International (ASX:MVP). Previous roles included Managing Director of CVC Venture Managers (private equity managers), Managing Director of Vita Life Sciences (ASX:VSC) and Cyclopharm (ASX:CYC), as well as roles at PriceWaterhouseCoopers, National Australia Bank and KPMG in both London and Melbourne.
Mr Philip Robert Nicholas Jacobsen Non-Executive Deputy ChairmanNon-Executive Director Jan 2015
Mr Jacobsen is an experienced public company director, he co-founded Premier Artists in 1975 and The Frontier Touring Company in 1979. He serves as a director of Liberation Music, Premier Artists, The Harbour Agency and Jacobsen Bloodstock. Former Chair of MCM Entertainment Group, Philip brings to the Board a 45 plus year history of applying solid fiscal accounting perspectives to an emerging business model in a constantly changing, high demand marketplace. Philip is also an Associate of Chartered Institute of Secretaries ACIS. He is also chairman of Risk Committee.
Ms Jennifer (Jenni) Pilcher Non-Executive Director Sep 2020
Ms Pilcher has senior executive experience in the medical and biotechnology sectors and is currently the Chief Financial Officer and Company Secretary of Mach7 Technologies (ASX:M7T). She has previously held executive roles with Alchemia Limited (ASX:ACL) and Mesoblast Limited (ASX:MSB).
Mr Geoffrey(Geoff) Ronald Pearce Non-Executive Director Apr 2016
Mr Pearce is a entrepreneur and businessman with more than 40 years experience in the personal care industry. He established and owned Scental Pacific Pty Ltd and grew the business to become Victoria's largest manufacturer of personal care products before selling it to the Smorgon Family. He later built a contract manufacturing business, Beautiworx Australia Pty Ltd, which was also sold. Geoff currently owns The Continental Group, which supplies pharmaceutical packaging and raw materials and has developed alliances with some of the world's leading herbal extract manufacturers. He has experience in areas including manufacturing, procurement, distribution and regulatory affairs. He is also member of Risk and Capital Committees.
Mr Peter Crock Chief Executive Officer
-
Ms Geraldine Farrell Company Secretary Dec 2019
-
Peter Crock Chief Executive Officer
-
Greg Bullock Chief Financial Officer
-
Shane Duncan Chief Operating officer
-
Geoff Aldred Chief Projects & Information Officer
-
Geraldine Farrell Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Aurora Cannabis Inc 31,956,347 16.37%
Flag Capital Pty Ltd 6,880,953 3.53%
Mullacam Pty Ltd <Atf The Mccallum Family Super Fund>/Allan Mccallum 5,580,000 2.86%
Supernova Fund Pty Ltd <Am & Em Stella Benefita/C> 4,602,696 2.36%
National Nominees Limited 4,368,538 2.24%
Mr Philip Jacobsen & Mrs Maxine Jacobsen 4,094,518 2.10%
Grapefull Pty Ltd/Doug & Ann Rathbone 2,331,185 1.19%
Hardmail Pty Ltd 2,056,852 1.05%
Zalm Therapeutics 1,983,890 1.02%
J P Morgan Nominees Australia Pty Limited 1,836,700 0.94%
Egea Pty Ltd/G Pearce & B Pearce 1,554,195 0.80%
HSBC Custody Nominees (Australia) Limited 1,342,227 0.69%
Mr Raymond Thomas Hobson & Mrs Rhonda Ellen Hobson 1,312,500 0.67%
Australian Businesspoint Pty Ltd 1,250,000 0.64%
Samada Street Nominees Pty Ltd 1,233,118 0.63%
Chevron Corporation Pty Ltd 1,227,385 0.63%
Commonwealth Scientific And Industrial Research Organisation 1,212,938 0.62%
Citicorp Nominees Pty Limited 1,167,441 0.60%
Bnp Paribas Nominees Pty Ltd 1,164,158 0.60%
Estelville Nominees Proprietary Limited 1,150,000 0.59%

Profile

since

Note